Fondaparinux Sodium
ATC B01AX05 · 4 markets · 12 records
Fondaparinux Sodium
Forms
AU 4 records · 4 strengths
- 10 mginjectionARIXTRA fondaparinux sodium 2.5mg/0.5mL solution for injection syringe
- 7.5 mginjectionARIXTRA fondaparinux sodium 2.5mg/0.5mL solution for injection syringe
- 5 mginjectionARIXTRA fondaparinux sodium 2.5mg/0.5mL solution for injection syringe
- 2.5 mginjectionARIXTRA fondaparinux sodium 2.5mg/0.5mL solution for injection syringe
SG 4 records · 3 strengths
- 2.5 mg/0.5 mLinjectionARIXTRA solution forDIVITI SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 2.5MG/0.5ML
- 7.5 mg/0.6 mLinjectionARIXTRA solution for
- 5 mg/0.4 mLinjectionARIXTRA solution for
HK 2 records · 1 strengths
Records without a stated strength · 1 ARIXTRA PRE-FILL SYR FOR INJ 2.5MG/0.5ML、ARIXTRA SOLUTION FOR INJ 7.5MG/0.6ML
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Arixtra
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.